Intel Capital backs Synthego
Silicon Valley-based Synthego, a provider of genome engineering solutions, has secured an undisclosed amount of funding. The investor was Intel Capital.
20 October 2017•1 min read
Silicon Valley-based Synthego, a provider of genome engineering solutions, has secured an undisclosed amount of funding. The investor was Intel Capital.
